R&D Systems™ Recombinant Human Integrin alpha V beta 1 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Integrin alpha V beta 1 Protein is derived from CHO. The Recombinant Human Integrin alpha V beta 1 Protein has been validated for the following applications: Bioactivity.

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 3685
• Molecular Weight (g/mol): 115 kDa ( alpha V subunit) and 86 kDa ( beta 1 subunit)
• Quantity: 1 mg
• Source: Chinese Hamster Ovary cell line,CHO-derived human Integrin alpha V beta 1 protein, (N-terminus) Human Integrin alpha V (Phe31-Val992) Accession &Num; NP_002201 GGGSGGGSGGGS Acidic Tail HHHHHH Human Integrin beta 1 (Gln21-Asp728) Accession &Num; P05556 GGGSGGGSGGGS Basic Tail (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <1.0 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500μg/mL in water.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.